Growth factor mediated signaling in pancreatic pathogenesis

Debashis Nandy, Debabrata Mukhopadhyay

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Functionally, the pancreas consists of two types of tissues: exocrine and endocrine. Exocrine pancreatic disorders mainly involve acute and chronic pancreatitis. Acute pancreatitis typically is benign, while chronic pancreatitis is considered a risk factor for developing pancreatic cancer. Pancreatic carcinoma is the fourth leading cause of cancer related deaths worldwide. Most pancreatic cancers develop in the exocrine tissues. Endocrine pancreatic tumors are more uncommon, and typically are less aggressive than exocrine tumors. However, the endocrine pancreatic disorder, diabetes, is a dominant cause of morbidity and mortality. Importantly, different growth factors and their receptors play critical roles in pancreatic pathogenesis. Hence, an improved understanding of how various growth factors affect pancreatitis and pancreatic carcinoma is necessary to determine appropriate treatment. This chapter describes the role of different growth factors such as vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF), platelet derived growth factor (PDGF), fibroblast growth factor (FGF), epidermal growth factor (EGF), and transforming growth factor (TGF) in various pancreatic pathophysiologies. Finally, the crosstalk between different growth factor axes and their respective signaling mechanisms, which are involved in pancreatitis and pancreatic carcinoma, are also discussed.

Original languageEnglish (US)
Pages (from-to)841-871
Number of pages31
JournalCancers
Volume3
Issue number1
DOIs
StatePublished - Mar 2011

Fingerprint

Pancreatitis
Intercellular Signaling Peptides and Proteins
Chronic Pancreatitis
Pancreatic Neoplasms
Neoplasms
Growth Factor Receptors
Fibroblast Growth Factors
Platelet-Derived Growth Factor
Transforming Growth Factors
Somatomedins
Epidermal Growth Factor
Vascular Endothelial Growth Factor A
Pancreas
Morbidity
Mortality
Pancreatic Carcinoma

Keywords

  • Growth factors
  • Pancreatic carcinoma
  • Pancreatitis
  • Signaling

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Growth factor mediated signaling in pancreatic pathogenesis. / Nandy, Debashis; Mukhopadhyay, Debabrata.

In: Cancers, Vol. 3, No. 1, 03.2011, p. 841-871.

Research output: Contribution to journalArticle

@article{47c4c2ec851e4af081d009c286d40fe5,
title = "Growth factor mediated signaling in pancreatic pathogenesis",
abstract = "Functionally, the pancreas consists of two types of tissues: exocrine and endocrine. Exocrine pancreatic disorders mainly involve acute and chronic pancreatitis. Acute pancreatitis typically is benign, while chronic pancreatitis is considered a risk factor for developing pancreatic cancer. Pancreatic carcinoma is the fourth leading cause of cancer related deaths worldwide. Most pancreatic cancers develop in the exocrine tissues. Endocrine pancreatic tumors are more uncommon, and typically are less aggressive than exocrine tumors. However, the endocrine pancreatic disorder, diabetes, is a dominant cause of morbidity and mortality. Importantly, different growth factors and their receptors play critical roles in pancreatic pathogenesis. Hence, an improved understanding of how various growth factors affect pancreatitis and pancreatic carcinoma is necessary to determine appropriate treatment. This chapter describes the role of different growth factors such as vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF), platelet derived growth factor (PDGF), fibroblast growth factor (FGF), epidermal growth factor (EGF), and transforming growth factor (TGF) in various pancreatic pathophysiologies. Finally, the crosstalk between different growth factor axes and their respective signaling mechanisms, which are involved in pancreatitis and pancreatic carcinoma, are also discussed.",
keywords = "Growth factors, Pancreatic carcinoma, Pancreatitis, Signaling",
author = "Debashis Nandy and Debabrata Mukhopadhyay",
year = "2011",
month = "3",
doi = "10.3390/cancers3010841",
language = "English (US)",
volume = "3",
pages = "841--871",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "1",

}

TY - JOUR

T1 - Growth factor mediated signaling in pancreatic pathogenesis

AU - Nandy, Debashis

AU - Mukhopadhyay, Debabrata

PY - 2011/3

Y1 - 2011/3

N2 - Functionally, the pancreas consists of two types of tissues: exocrine and endocrine. Exocrine pancreatic disorders mainly involve acute and chronic pancreatitis. Acute pancreatitis typically is benign, while chronic pancreatitis is considered a risk factor for developing pancreatic cancer. Pancreatic carcinoma is the fourth leading cause of cancer related deaths worldwide. Most pancreatic cancers develop in the exocrine tissues. Endocrine pancreatic tumors are more uncommon, and typically are less aggressive than exocrine tumors. However, the endocrine pancreatic disorder, diabetes, is a dominant cause of morbidity and mortality. Importantly, different growth factors and their receptors play critical roles in pancreatic pathogenesis. Hence, an improved understanding of how various growth factors affect pancreatitis and pancreatic carcinoma is necessary to determine appropriate treatment. This chapter describes the role of different growth factors such as vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF), platelet derived growth factor (PDGF), fibroblast growth factor (FGF), epidermal growth factor (EGF), and transforming growth factor (TGF) in various pancreatic pathophysiologies. Finally, the crosstalk between different growth factor axes and their respective signaling mechanisms, which are involved in pancreatitis and pancreatic carcinoma, are also discussed.

AB - Functionally, the pancreas consists of two types of tissues: exocrine and endocrine. Exocrine pancreatic disorders mainly involve acute and chronic pancreatitis. Acute pancreatitis typically is benign, while chronic pancreatitis is considered a risk factor for developing pancreatic cancer. Pancreatic carcinoma is the fourth leading cause of cancer related deaths worldwide. Most pancreatic cancers develop in the exocrine tissues. Endocrine pancreatic tumors are more uncommon, and typically are less aggressive than exocrine tumors. However, the endocrine pancreatic disorder, diabetes, is a dominant cause of morbidity and mortality. Importantly, different growth factors and their receptors play critical roles in pancreatic pathogenesis. Hence, an improved understanding of how various growth factors affect pancreatitis and pancreatic carcinoma is necessary to determine appropriate treatment. This chapter describes the role of different growth factors such as vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF), platelet derived growth factor (PDGF), fibroblast growth factor (FGF), epidermal growth factor (EGF), and transforming growth factor (TGF) in various pancreatic pathophysiologies. Finally, the crosstalk between different growth factor axes and their respective signaling mechanisms, which are involved in pancreatitis and pancreatic carcinoma, are also discussed.

KW - Growth factors

KW - Pancreatic carcinoma

KW - Pancreatitis

KW - Signaling

UR - http://www.scopus.com/inward/record.url?scp=79953721180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953721180&partnerID=8YFLogxK

U2 - 10.3390/cancers3010841

DO - 10.3390/cancers3010841

M3 - Article

C2 - 24212642

AN - SCOPUS:79953721180

VL - 3

SP - 841

EP - 871

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 1

ER -